5-MTHF Dosage: Guidelines for Safe and Effective Use

Dosing for 5-methyltetrahydrofolate (5-MTHF), the biologically active form of folate, varies widely depending on what it is being used for. General wellness and pregnancy supplements typically contain 400 to 1,000 micrograms (mcg), while clinical applications like treatment-resistant depression have used doses as high as 15 milligrams (mg) per day under medical supervision. The range is broad because 5-MTHF serves different roles at different doses, and the regulatory landscape treats it differently from standard folic acid in ways that matter for how much you can safely take.

Why 5-MTHF Instead of Folic Acid

Folic acid is the synthetic folate added to fortified foods and most standard supplements. It has no biological activity on its own. Your liver has to convert it through several enzymatic steps before it becomes 5-MTHF, which is the form your cells actually use for methylation reactions, DNA synthesis, and neurotransmitter production.¹ That conversion relies on an enzyme called dihydrofolate reductase, and the process is slow enough that when people take large amounts of folic acid, some of it circulates in the blood unconverted. This leftover is called unmetabolized folic acid (UMFA), and there is growing interest in whether chronic UMFA accumulation poses health risks.

5-MTHF bypasses all of that. Because it is already in the reduced, methylated form, it does not need enzymatic activation and is available for use immediately after absorption.² This makes it especially relevant for people who carry genetic variants in the MTHFR gene, which encodes one of the enzymes involved in converting folic acid to its active form. These variants are common in some populations and can reduce the efficiency of that conversion, meaning those individuals get less usable folate from the same dose of folic acid. 5-MTHF sidesteps the issue entirely by delivering the end product directly.

Standard Dosage Ranges by Use

There is no single recommended dose for 5-MTHF because it is used in several distinct clinical and wellness contexts. Here are the ranges supported by research and clinical practice:

General folate needs: 400 mcg per day is the amount typically recommended for most adults to meet daily folate requirements. This mirrors the standard recommendation for folic acid.
Pregnancy and preconception: 400 to 800 mcg per day, sometimes up to 1,000 mcg, depending on individual risk factors and physician guidance. The goal is neural tube defect prevention and support for rapid cell division.
Depression (adjunctive therapy): 15 mg per day, which is 15,000 mcg. This dose was used in clinical trials for patients who did not respond adequately to SSRI antidepressants alone.³
Diabetic neuropathy: Studied at various doses, typically in the milligram range, with evidence of benefit for symptom relief and nerve function.⁴

The jump from 400-1,000 mcg to 15 mg is enormous, and it reflects the difference between meeting a nutritional requirement and using a nutrient at pharmacological doses for a specific medical condition. That distinction matters for safety, which I will get to below.

Dosing in Pregnancy

Folate supplementation before and during early pregnancy is one of the most well-established preventive measures in prenatal care, primarily for reducing the risk of neural tube defects like spina bifida. Most health agencies recommend 400 to 800 mcg of folate daily for women of childbearing age, and 5-MTHF can serve as the folate source in this range.

A randomized controlled trial comparing prenatal multivitamins containing 5-MTHF against those with folic acid found that both maintained adequate total folate levels in the blood. But the 5-MTHF group had dramatically less unmetabolized folic acid: only about 7% of participants had detectable UMFA in their blood, compared with 31% in the folic acid group. UMFA levels in placental tissue were also lower in the 5-MTHF group.⁵ This matters because the long-term effects of UMFA exposure in pregnant women and developing fetuses are not fully understood, but the ability to maintain folate status without generating UMFA is a practical advantage.

There is also retrospective evidence suggesting that mothers who began taking 5-MTHF during their first trimester had a lower incidence of preeclampsia, though this has not yet been confirmed in large prospective trials.² For pregnancy, the dosing itself is not radically different from folic acid recommendations. The argument for 5-MTHF here is less about needing a higher dose and more about getting a cleaner metabolic outcome at the same dose.

The 15 mg Dose for Depression

The most striking dosing data for 5-MTHF comes from psychiatry. Two randomized, double-blind trials tested L-methylfolate (the pharmaceutical name for 5-MTHF) as an add-on to SSRI antidepressants in patients whose depression had not responded to the SSRI alone. At 15 mg per day, L-methylfolate showed significantly better response rates and greater improvement in depression scores compared with placebo. The number needed to treat was roughly six, meaning about one in six patients experienced a meaningful response that they would not have had on the SSRI alone. Adverse event rates were no different from placebo, which is a notable safety signal at a dose that is roughly 37 times the standard daily folate intake.³

Clinicians who prescribe this typically start at a lower dose and titrate up. A case study documenting monotherapy (5-MTHF used on its own, not alongside an SSRI) for treatment-resistant depression described a slow titration to an eventual therapeutic dose of 15 mg per day.⁶ This gradual approach makes sense because some people experience headaches, irritability, or insomnia when starting high-dose methylfolate abruptly, likely related to the sudden increase in methyl group availability. Starting low and increasing over days to weeks gives the body time to adjust.

It is worth emphasizing that 15 mg per day is a prescription-level intervention, not a supplement strategy. In the United States, L-methylfolate at this dose is available as a medical food (brand name Deplin, among others), which occupies a regulatory gray area between supplement and drug. You should not self-prescribe this dose for mood symptoms without medical guidance, both because diagnosing treatment-resistant depression requires clinical evaluation and because the dose interacts with the broader picture of your medications and health status.

Upper Intake Limits and How 5-MTHF Fits In

Regulatory bodies have historically set tolerable upper intake levels (ULs) for folic acid, not for 5-MTHF, because folic acid was the dominant supplemental form. But this is changing. The European Food Safety Authority (EFSA) updated its scientific opinion on folate and established that the UL for adults of 1,000 mcg per day now applies to folic acid, 5-MTHF glucosamine salt, and L-5-MTHF calcium salt combined.⁷ For children, the limits are lower: 200 mcg per day for ages one to three, scaling up to 800 mcg per day for ages 15 to 17.

The original rationale for the folic acid UL was not toxicity in the traditional sense. High-dose folic acid can mask the blood-related signs of vitamin B12 deficiency, specifically by correcting the anemia while leaving the neurological damage to progress undetected. 5-MTHF does not carry this masking risk in the same way, which some researchers have argued should exempt it from the same UL.² EFSA, however, applied the UL to all these forms as a precautionary measure, largely because long-term safety data at high doses of 5-MTHF in the general population remain limited.

This creates an interesting tension. The 15 mg clinical depression dose is 15 times the EFSA upper limit for general supplementation. That does not mean 15 mg is dangerous. It means that dose sits squarely in medical territory, where a clinician is weighing the benefit of treating a serious psychiatric condition against a theoretical risk profile that has so far shown minimal adverse effects in trials. For people taking 5-MTHF for general health or pregnancy, staying at or below 1,000 mcg per day is the standard guidance.

Salt Forms and Bioavailability Differences

Not all 5-MTHF supplements are created equal, and this is an underappreciated factor in dosing. The molecule itself is chemically fragile and degrades easily, so it is typically sold as a salt. The three main salt forms on the market are calcium salt (often labeled as “Metafolin” or “Quatrefolic”), glucosamine salt, and calcium salt in crystal form C. These are not interchangeable in terms of how well your body absorbs them or how stable they remain on the shelf.

A pharmacokinetic study in rats found that the crystal form C of calcium salt (MTHF CAC) had roughly 3.5 times the relative bioavailability of standard calcium salt and about 2.2 times that of the glucosamine salt. The crystal form was also the most chemically stable, degrading the slowest under storage conditions.⁸ While rat pharmacokinetics do not translate directly to humans, the stability findings matter because a supplement that degrades before you take it delivers less active ingredient than the label claims.

For practical purposes, this means that when you compare two 5-MTHF supplements at the same labeled dose, you may be getting meaningfully different amounts of usable folate depending on the salt form and how the product has been stored. Look for the specific salt form on the label. Calcium salt formulations (particularly the branded Quatrefolic or Metafolin forms) have the most market presence and the best stability data. Glucosamine salt is also authorized by EFSA but appears to degrade somewhat faster.

Cognitive Decline and Where Evidence Falls Short

Folate supplementation is sometimes marketed as a brain-health intervention, particularly for older adults concerned about cognitive decline or dementia. The logic is reasonable on paper: folate is involved in homocysteine metabolism, and elevated homocysteine is associated with increased dementia risk. But the intervention data has not kept pace with the mechanistic theory. A review of the evidence found no consistent demonstration that folic acid supplementation improves cognitive function or slows cognitive decline in either healthy older adults or those already showing cognitive impairment.⁹

Whether 5-MTHF specifically performs any differently from folic acid in this context is largely untested. The theoretical advantage (better bioavailability, no UMFA accumulation) exists, but theoretical advantages do not always translate into clinical outcomes. If you are considering 5-MTHF specifically for cognitive protection, the honest answer is that the evidence does not yet support that use at any dose. Correcting a genuine folate deficiency is a different matter and would be expected to improve any symptoms caused by the deficiency itself, but that is not the same as using supplemental folate to prevent or treat dementia.

Diabetic Neuropathy and Nerve Health

A more promising area for high-dose 5-MTHF is diabetic peripheral neuropathy, the nerve damage that affects a large proportion of people with diabetes. A narrative review covering one randomized controlled trial and several open-label studies found that L-methylfolate had significant beneficial effects on neuropathy symptoms. The benefits appeared to go beyond simply reducing pain and tingling; the evidence suggested effects on the underlying nerve damage itself, with minimal adverse effects reported.⁴

The mechanism likely involves folate’s role in methylation and homocysteine regulation, both of which are disrupted in diabetes. Elevated homocysteine damages blood vessels, including the small vessels that supply peripheral nerves. By improving methylation, 5-MTHF may help protect those vessels. The evidence here is still relatively thin compared to the depression data, but it is heading in a direction that could eventually support specific dosing recommendations for neuropathy patients. If your doctor has suggested methylfolate for neuropathy, the clinical doses used in these studies were in the milligram range, well above general supplementation levels.

Folate Receptor Autoantibodies and Autism Spectrum Disorder

One of the more specialized applications of folate supplementation involves children with autism spectrum disorder (ASD) who have autoantibodies that block the folate receptor alpha. These autoantibodies have been identified in a large proportion of children with ASD, and research has shown that antibody levels correlate with folate concentrations in cerebrospinal fluid. When the receptor is blocked, folate has difficulty entering the brain even if blood levels are normal.¹⁰

The primary treatment studied for this specific situation is d,l-leucovorin (folinic acid), a reduced folate that can bypass the blocked receptor by using an alternate transport pathway called the reduced folate carrier. Studies ranging from case series to double-blind placebo-controlled trials have reported substantial improvement in particular symptoms, especially in children who test positive for the autoantibodies. This is not the same as 5-MTHF supplementation, and the dosing is different. It falls under pediatric neurology rather than general supplement guidance, and is managed by specialists who test for the autoantibodies and monitor cerebrospinal fluid folate levels. But it illustrates how the type of folate used and the route it takes into the brain can make a meaningful clinical difference.

Stability Challenges in Food Fortification

If 5-MTHF is better absorbed and avoids the UMFA problem, a natural question is why we do not simply use it instead of folic acid in fortified foods like bread and flour. The answer is stability. Folic acid is a remarkably tough molecule that survives industrial food processing, storage, and cooking with relatively little loss. 5-MTHF, in its free form, does not hold up nearly as well.

Research on fortifying noodle flour with 5-MTHF found that the free form of the vitamin suffered the greatest losses during cooking. However, when 5-MTHF was microencapsulated (enclosed in a protective coating), its recovery after cooking was comparable to folic acid. Adding sodium ascorbate (a form of vitamin C) further stabilized the folate through both boiling and frying.¹¹ Microencapsulated 5-MTHF also dispersed more evenly through the flour than the free forms of either 5-MTHF or folic acid, which is important for ensuring each serving of a fortified food contains a consistent amount.

These findings suggest that the technical barriers to using 5-MTHF in food fortification are solvable but add cost and complexity. Whether public health programs will eventually shift from folic acid to 5-MTHF in fortified staple foods is still an open question, influenced as much by economics and regulatory inertia as by the science. For now, folic acid remains the only folate form authorized for food fortification in most countries, which means the 5-MTHF choice is one individuals make at the supplement shelf, not one that gets made for them in the food supply.

Practical Guidance for Choosing a Dose

If you are taking 5-MTHF for general health or because you carry MTHFR variants and want to ensure adequate folate status, 400 to 800 mcg per day covers what most adults need. This is the range where you are replacing what folic acid would have provided, just in a form that skips the conversion bottleneck. You do not need a prescription, and this dose is widely available in supplement form.

If you are pregnant or planning to become pregnant, 400 to 1,000 mcg is the standard range. Some prenatal multivitamins now include 5-MTHF instead of folic acid, and the trial data supports this as an effective alternative that maintains folate status while reducing UMFA exposure.⁵ Check with your prenatal care provider, especially if you have a history of neural tube defect-affected pregnancies, as higher doses may be appropriate in that situation.

For depression, neuropathy, or other medical conditions, the doses are much higher and belong in a clinical conversation. The 15 mg dose used in depression trials is effective and well tolerated in that research context, but it is a medical intervention that should be initiated and monitored by a healthcare provider. Self-dosing at milligram levels based on internet research is a poor substitute for having someone who understands your full clinical picture make the call. The same applies to pediatric uses like the folate receptor autoantibody-related treatment in ASD, which involves different folate forms entirely and requires specialist oversight.

Regardless of dose, pay attention to the salt form listed on the label. Calcium salt formulations have the strongest stability and bioavailability data.⁸ Store your supplements away from heat and light, as 5-MTHF degrades faster than folic acid under poor storage conditions. And if you are taking other supplements or medications that affect folate metabolism, including certain anti-seizure drugs, mention your 5-MTHF use to your pharmacist or physician to check for interactions.